日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II study of sunitinib in men with advanced prostate cancer

舒尼替尼治疗晚期前列腺癌男性患者的II期研究

Dror Michaelson, M; Regan, M M; Oh, W K; Kaufman, D S; Olivier, K; Michaelson, S Z; Spicer, B; Gurski, C; Kantoff, P W; Smith, M R

Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma

舒尼替尼对贝伐单抗耐药转移性肾细胞癌患者的抗肿瘤活性和生物标志物分析

Brian I Rini, M Dror Michaelson, Jonathan E Rosenberg, Ronald M Bukowski, Jeffrey A Sosman, Walter M Stadler, Thomas E Hutson, Kim Margolin, Charles S Harmon, Samuel E DePrimo, Sindy T Kim, Isan Chen, Daniel J George